Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses T Rowland, BI Perry, R Upthegrove, N Barnes, J Chatterjee, D Gallacher, ... The British Journal of Psychiatry 213 (3), 514-525, 2018 | 160 | 2018 |
Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis R Mottram, WL Knerr, D Gallacher, H Fraser, L Al-Khudairy, A Ayorinde, ... BMJ open 11 (11), 2021 | 29 | 2021 |
Extrapolating Parametric Survival Models in Health Technology Assessment: A Simulation Study D Gallacher, P Kimani, N Stallard Medical Decision Making 41 (1), 37-50, 2020 | 26 | 2020 |
Mode of birth and development of maternal postnatal post‐traumatic stress disorder: A mixed‐methods systematic review and meta‐analysis J Carter, D Bick, D Gallacher, YS Chang Birth 49 (4), 616-627, 2022 | 19 | 2022 |
How do pharmaceutical companies model survival of cancer patients? A review of NICE single technology appraisals in 2017 D Gallacher, P Auguste, M Connock International journal of technology assessment in health care 35 (2), 160-167, 2019 | 19 | 2019 |
Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation Fraser H, Gallacher D, Achana F, Court R, Taylor-Phillips S, Nduka C ... Health Technology Assessment 24 (31), 2020 | 18* | 2020 |
Derivation and internal validation of the screening to enhance prehospital identification of sepsis (SEPSIS) score in adults on arrival at the emergency department MA Smyth, D Gallacher, PK Kimani, M Ragoo, M Ward, GD Perkins Scandinavian journal of trauma, resuscitation and emergency medicine 27, 1-13, 2019 | 17 | 2019 |
Efficacy, safety, and dose‐dependence of the analgesic effects of opioid therapy for people with osteoarthritis: systematic review and meta‐analysis C Abdel Shaheed, W Awal, G Zhang, SE Gilbert, D Gallacher, ... Medical Journal of Australia 216 (6), 305-311, 2022 | 15 | 2022 |
Pembrolizumab for previously treated advanced or metastatic urothelial cancer: an evidence review group perspective of a NICE single technology appraisal D Gallacher, X Armoiry, P Auguste, R Court, T Mantopoulos, J Patterson, ... PharmacoEconomics 37, 19-27, 2019 | 13 | 2019 |
Court R, Taylor-Phillips S, Nduka C, et al. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and … H Fraser, D Gallacher, F Achana Health Technol Assess 24 (31), 1-232, 2020 | 12 | 2020 |
A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and … D Gallacher, P Auguste, P Royle, H Mistry, X Armoiry Clinical Drug Investigation 39 (12), 1153-1174, 2019 | 9 | 2019 |
Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2+/− Mice Is Superior to Everolimus Alone J Yang, PA Samsel, K Narov, A Jones, D Gallacher, J Gallacher, ... Neoplasia 19 (2), 112-120, 2017 | 9 | 2017 |
Assessing the health economic agreement of different data sources D Gallacher, F Achana Stata Journal 18 (1), 223-233, 2018 | 8 | 2018 |
Extrapolating Parametric Survival Models in Health Technology Assessment Using Model Averaging: A Simulation Study D Gallacher, P Kimani, N Stallard Medical Decision Making 41 (4), 476-484, 2021 | 7 | 2021 |
Systematic review and meta‐analysis of the metabolic effects of modified‐release hydrocortisone versus standard glucocorticoid replacement therapy in adults with adrenal … CA Bannon, D Gallacher, P Hanson, HS Randeva, MO Weickert, ... Clinical Endocrinology 93 (6), 637-651, 2020 | 7 | 2020 |
Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data F Achana, D Gallacher, R Oppong, S Kim, S Petrou, J Mason, M Crowther Medical Decision Making 41 (6), 667-684, 2021 | 5 | 2021 |
Ankle injury rehabilitation (AIR): a feasibility randomised controlled trial comparing functional bracing to plaster cast in the treatment of adult ankle fractures RS Kearney, R McKeown, D Gallacher, J Brown, D Mistry, N Parsons, ... Pilot and Feasibility Studies 5 (1), 1-8, 2019 | 5 | 2019 |
Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations D Gallacher, P Kimani, N Stallard PharmacoEconomics, 1-12, 2022 | 3 | 2022 |
Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost‐effectiveness assessment on health utility for targeted medicines D Gallacher, N Stallard, P Kimani, E Gökalp, J Branke Health Economics 31 (2), 417-430, 2022 | 2* | 2022 |
HEABS: Stata module to calculate the ICER and Net Benefit for up to two datasets D Gallacher Boston College Department of Economics, 2020 | 2 | 2020 |